The choline chloride market growth worldwide is predicted to be driven by the increasing demand for meat consumption, such as ...

Reported positive six-month data from ADVANCED-2 trial of TARA-002 in patients with NMIBCCompleted approximately $100 million public offering, ...

In December 2024, the Company reported positive interim results from its ongoing Phase 2 open-label ADVANCED-2 trial in in ...

Additionally, Protara is developing IV Choline Chloride, an investigational phospholipid substrate replacement for patients on parenteral nutrition who are otherwise unable to meet their choline ...

One of its biggest subsidiaries is BCP Ingredients, which manufactures ethylene oxide, used in medical equipment sterilization, and choline chloride, which is used in animal feed for chickens and cows ...